Maija Konstenius

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: EUROPEAN ADDICTION RESEARCH. 2024;30(1):1-13

The Effect of Methylphenidate on Cognition in Patients with Comorbid Attention Deficit/Hyperactivity Disorder and Amphetamine Use Disorder: An Exploratory Single-Blinded within-Subject Study

Brynte C; Konstenius M; Khemiri L; Backer A; Guterstam J; Levin FR; Jayaram-Lindstrom N; Franck J
Article: BMC PSYCHIATRY. 2023;23(1):537

Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorder

Brynte C; Khemiri L; Stenstrom H; Konstenius M; Lindstrom N-J; Franck J
Article: SPAN J PSYCHIATRY MENT HEALTH. 2023;16(1):11-15

Validity of the ADHD module of the Mini International Neuropsychiatric Interview PLUS for screening of adult ADHD in treatment seeking substance use disorder patients: ADHD screening with MINI-Plus

Palma-alvarez RF; Barta C; Carpentier PJ; Carruthers S; Crunelle CL; Demetrovics Z; Dom G; V. Faraone S; Franck J; Johnson B; Kapitany-Foveny M; Kaye S; Konstenius M; Matthys F; Moggi F; Moller M; Schellekens A; Skutle A; van de Glindu G; Oortmerssen KVE-V; Verspreet S; Schoevers RA; Wallhed S; Levin FR; Grau-Lopez L; Casas M; Brink WVD; Ramos-Quiroga JA
Article: BMC PSYCHIATRY. 2022;22(1):625

The clinical course of comorbid substance use disorder and attention deficit/hyperactivity disorder: protocol and clinical characteristics of the INCAS study

Brynte C; Aeschlimann M; Barta C; Begeman AHA; Backer A; Crunelle CL; Daigre C; De Fuentes-Merillas L; Demetrovics Z; Dom G; Grau Lopez L; Icick R; Johnson B; Joostens P; Kapitany-Foveny M; Karsinti E; Kiefer F; Konstenius M; Levin FR; Luderer M; Markus W; Matthys F; Moggi F; Felipe Palma-Alvarez R; Paraskevopoulou M; Antoni Ramos-Quiroga J; Schellekens A; Soravia LM; Therribout N; Thomas A; van de Glind G; van Kernebeek MW; Vollstaedt-Klein S; Vorspan F; van den Brink W; Franck J
Article: ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE. 2022;50(1):54-67

International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder

Ozgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; Gonzalez RA; Grau-Lopez L; Groenman AP; Hemphala M; Icick R; Johnson B; Kaess M; Kapitany-Foveny M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstadt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Article: BMC PSYCHIATRY. 2021;21(1):458

Self-rated impulsivity in healthy individuals, substance use disorder and ADHD: psychometric properties of the Swedish Barratt impulsiveness scale

Khemiri L; Brynte C; Konstenius M; Guterstam J; Rosendahl I; Franck J; Jayaram-Lindstrom N
Article: EUROPEAN ADDICTION RESEARCH. 2020;26(4-5):223-232

International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder

Ozgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Blanco CD; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; Gonzalez RA; Grau-Lopez L; Groenman AP; Hemphala M; Icick R; Johnson B; Kaess M; Kapitany-Foveny M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Antoni Ramos-Quiroga J; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstadt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Article: EUROPEAN ADDICTION RESEARCH. 2020;26(4-5):211-222

Onset and Severity of Early Disruptive Behavioral Disorders in Treatment-Seeking Substance Use Disorder Patients with and without Attention-Deficit/Hyperactivity Disorder

Gonzalez RA; Velez-Pastrana MC; Blankers M; Backer A; Konstenius M; Holtmann M; Levin FR; Noack M; Kaye S; Demetrovics Z; van de Glind G; van den Brink W; Schellekens A
Article: JOURNAL OF ATTENTION DISORDERS. 2019;23(12):1438-1453

Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers

Kaye S; Ramos-Quiroga JA; van de Glind G; Levin FR; Faraone SV; Allsop S; Degenhardt L; Moggi F; Barta C; Konstenius M; Franck J; Skutle A; Bu E-T; Koeter MWJ; Demetrovics Z; Kapitany-Foeveny M; Schoevers RA; van Emmerik-van Oortmerssen K; Carpentier P-J; Dom G; Verspreet S; Crunelle CL; Young JT; Carruthers S; Cassar J; Fatseas M; Auriacombe M; Johnson B; Dunn M; Slobodin O; van den Brink W
Article: ADDICTIVE BEHAVIORS. 2017;65:118-124

Childhood trauma exposure in substance use disorder patients with and without ADHD

Konstenius M; Leifman A; van Emmerik-van Oortmerssen K; van de Glind G; Franck J; Moggi F; Antoni Ramos-Quiroga J; Levin FR; Carpentier PJ; Skutle A; Buj E-T; Kaye S; Demetrovics Z; Barta C; Auriecomb M; Fatseas M; Johnson B; Faraone SV; Allsop S; Carruthers S; Schoevers RA; Verspreet S; Dom G; Koeter MWJ; van den Brink W
Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2016;36(3):222-228

Factors Associated With Adherence to Methylphenidate Treatment in Adult Patients With Attention-Deficit/Hyperactivity Disorder and Substance Use Disorders

Skoglund C; Brandt L; Almqvist C; D'Onofrio BM; Konstenius M; Franck J; Larsson H
Article: ADDICTIVE BEHAVIORS REPORTS. 2015;2:13-18

Early developmental, temperamental and educational problems in 'substance use disorder' patients with and without ADHD. Does ADHD make a difference?

Skutle A; Bu ETH; Jellestad FK; van Emmerik-van Oortmerssen K; Dom G; Verspreet S; Carpentier PJ; Ramos-Quiroga JA; Franck J; Konstenius M; Kaye S; Demetrovics Z; Barta C; Fatséas M; Auriacombe M; Johnson B; Faraone SV; Levin FR; Allsop S; Carruthers S; Schoevers RA; Koeter MWJ; van den Brink W; Moggi F; Møller M; van de Glind G
Article: EUROPEAN ADDICTION RESEARCH. 2015;21(4):188-194

Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study

Wapp M; van de Glind G; van Emmerik-van Oortmerssen K; Dom G; Verspreet S; Carpentier PJ; Ramos-Quiroga JA; Skutle A; Bu E-T; Franck J; Konstenius M; Kaye S; Demetrovics Z; Barta C; Fatseas M; Auriacombe M; Johnson B; Faraone SV; Levin FR; Allsop S; Carruthers S; Schoevers RA; Koeter MWJ; van den Brink W; Moggi F
Article: JOURNAL OF ATTENTION DISORDERS. 2015;19(1):44-52

An Epidemiological Study of ADHD, Substance Use, and Comorbid Problems in Incarcerated Women in Sweden

Konstenius M; Larsson H; Lundholm L; Philips B; van de Glind G; Jayaram-Lindstrom N; Franck J
Article: ADDICTION. 2014;109(3):440-449

Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial

Konstenius M; Jayaram-Lindstroem N; Guterstam J; Beck O; Philips B; Franck J
Article: ADDICTION. 2014;109(2):262-272

Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study

vanEmmerik-van Oortmerssen K; van de Glind G; Koeter MWJ; Allsop S; Auriacombe M; Barta C; Bu ETH; Burren Y; Carpentier P-J; Carruthers S; Casas M; Demetrovics Z; Dom G; Faraone SV; Fatseas M; Franck J; Johnson B; Kapitany-Foeveny M; Kaye S; Konstenius M; Levin FR; Moggi F; Moller M; Ramos-Quiroga JA; Schillinger A; Skutle A; Verspreet S; van den Brink W; Schoevers RA
Article: DRUG AND ALCOHOL DEPENDENCE. 2014;134:158-166

Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: Results from an international multi-center study exploring DSM-IV and DSM-5 criteria

van de Glind G; Konstenius M; Koeter MWJ; van Emmerik-van Oortmerssen K; Carpentier P-J; Kaye S; Degenhardt L; Skutle A; Franck J; Bu E-T; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitany-Foveny M; Fatseas M; Auriacombe M; Schillinger A; Moller M; Johnson B; Farone SV; Antoni Ramos-Quiroga J; Casas M; Allsop S; Carruthers S; Schoevers RA; Wallhed S; Barta C; Alleman P; Levin FR; van den Brink W
Article: DRUG AND ALCOHOL DEPENDENCE. 2013;132(3):587-596

Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients

van de Glind G; van den Brink W; Koeter MWJ; Carpentier P-J; van Emmerik-van Oortmerssen K; Kaye S; Skutle A; Bu E-TH; Franck J; Konstenius M; Moggi F; Dom G; Verspreet S; Demetrovics Z; Kapitany-Foeveny M; Fatseas M; Auriacombe M; Schillinger A; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Casas M; Allsop S; Carruthers S; Bartar C; Schoevers RA; Levin FR
Article: INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH. 2013;22(3):232-244

The International ADHD in Substance Use Disorders Prevalence (IASP) study: background, methods and study population

De Glind GV; Oortmerssen KVE-V; Carpentier PJ; Levin FR; Koeter MWJ; Barta C; Kaye S; Skutle A; Franck J; Konstenius M; Bu E-T; Moggi F; Dom G; Demetrovics Z; Fatseas M; Schillinger A; Kapitany-Foeveny M; Verspreet S; Seitz A; Johnson B; Faraone SV; Ramos-Quiroga JA; Allsop S; Carruthers S; Schoevers RA; Grp IR; Van den Brink W
Article: BMC PSYCHIATRY. 2012;12:221

Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Bramness JG; Gundersen OH; Guterstam J; Rognli EB; Konstenius M; Loberg E-M; Medhus S; Tanum L; Franck J
Article: DRUG AND ALCOHOL DEPENDENCE. 2010;108(1-2):130-133

Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: A pilot study

Konstenius M; Jayaram-Lindstrom N; Beck O; Franck J
Article: NEUROPSYCHOPHARMACOLOGY. 2008;33(8):1856-1863

Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence

Jayaram-Lindstrom N; Konstenius M; Eksborg S; Beck O; Hammarberg A; Franck J
Article: SCANDINAVIAN JOURNAL OF PSYCHOLOGY. 2005;46(3):285-296

An empirical look at the Defense Mechanism Test (DMT): reliability and construct validity.

Ekehammar B; Zuber I; Konstenius M-L
Visa fler

Alla övriga publikationer

Review: EUROPEAN ADDICTION RESEARCH. 2020;26(4-5):173-178

The International Collaboration on ADHD and Substance Abuse (ICASA): Mission, Results, and Future Activities

Van de Glind G; Brynte C; Skutle A; Kaye S; Konstenius M; Levin F; Mathys F; Demetrovics Z; Moggi F; Ramos-Quiroga JA; Schellekens A; Crunelle C; Dom G; van den Brink W; Franck J
Review: EUROPEAN ADDICTION RESEARCH. 2018;24(1):43-51

International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder

Crunelle CL; van den Brink W; Moggi F; Konstenius M; Franck J; Levin FR; van de Glind G; Demetrovics Z; Coetzee C; Luderer M; Schellekens A; Matthys F
Meeting abstract: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2017;27:S1073-S1074

The effect of methylphenidate on executive functioning in patients with co-morbid ADHD and stimulant use disorder

Brynte C; Konstenius M; Jayaram-Lindstrom N; Franck J
Thesis / dissertation: 2013

ADHD in substance use disorders : prevalence and pharmacotherapy

Konstenius, Maija

Anställningar

Anknuten till Forskning, Klinisk neurovetenskap, Karolinska Institutet, 2023-2024

Examina och utbildning

Medicine Doktorsexamen, Institutionen för klinisk neurovetenskap, Karolinska Institutet, 2013

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI